Omniverse Replicator: Synthetic Data for Industrial AI (2026)
Why NVIDIA Omniverse Replicator is becoming the default synthetic-data pipeline for industrial AI in 2026 — pipelines, domain randomization, ROI.
Implementing OPC UA Companion Specs: Hands-On Tutorial (2026)
Hands-on 2026 tutorial — implementing OPC UA companion specifications (Machinery, Pumps) on open62541 with full server and client code.
Implementing OPC UA Companion Specs: Hands-On Tutorial (2026)
Hands-on 2026 tutorial — implementing OPC UA companion specifications (Machinery, Pumps) on open62541 with full server and client code.
Zenoh for Industrial IoT: Reference Architecture (2026)
2026 reference architecture for Zenoh in industrial IoT — routers, peers, storages, ROS2 bridge, MQTT/DDS interoperability, and capacity planning.
TSN vs 5G URLLC: Deterministic Networking on the Factory Floor (2026)
TSN vs 5G URLLC compared for deterministic factory networking in 2026 — jitter, scheduling, integration cost, profiles, and a decision matrix.
Iceberg vs Delta vs Hudi for Industrial Lakehouse: 2026 ADR
ADR-style 2026 guide picking between Apache Iceberg, Delta Lake, and Apache Hudi for industrial IoT data lakehouse — trade-offs and decision matrix.
eBPF Observability with Pixie + Cilium: Tutorial (2026)
Step-by-step 2026 tutorial — install Pixie and Cilium Hubble, capture HTTP/gRPC/DB traces with eBPF, and design auto-instrumented Kubernetes observability.
Real-Time Risk Engine for Crypto Derivatives: Architecture (2026)
How to architect a real-time risk engine for crypto perpetuals and options in 2026 — funding, mark price, VaR, liquidations, and circuit breakers.
Arm Neoverse V3 Reshapes Enterprise Server Design (2026)
How Arm Neoverse V3 (Graviton 4, Cobalt 100, NVIDIA Grace) is rewriting enterprise server design in 2026 — performance, software ecosystem, migration patterns.
Cryo-EM at 1.2 Å: Atomic Resolution Milestone Explained (2026)
Why cryo-EM hitting 1.2 Å atomic resolution in 2026 matters — the science, the Krios G5 microscope, AI-driven processing, and drug discovery implications.